IDEAYA Biosciences (IDYA) Research & Development (2018 - 2026)

IDEAYA Biosciences has disclosed Research & Development across 9 years of filings, most recently posting $95.7 million for Q1 2026.

• Research & Development for Q1 2026 came in at $95.7 million, up 35.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $339.5 million (up 5.2% YoY), and the FY2025 annual result was $314.7 million, up 6.8% from the prior year.
• Research & Development came in at $95.7 million for Q1 2026 at IDEAYA Biosciences, up from $86.6 million in the prior quarter.
• In the past five years, Research & Development ranged from a high of $140.2 million in Q4 2024 to a low of $19.7 million in Q1 2022.
• The 5-year median for Research & Development is $42.8 million (2024), against an average of $54.4 million.
• Across the five-year window, Research & Development soared 261.58% in 2024 and tumbled 38.22% in 2025, its largest moves.
• IDEAYA Biosciences' Research & Development stood at $24.7 million in 2022, then soared by 56.88% to $38.8 million in 2023, then jumped by 261.58% to $140.2 million in 2024, then slumped by 38.22% to $86.6 million in 2025, then advanced by 10.54% to $95.7 million in 2026.
• The last three Research & Development figures came in at $95.7 million (Q1 2026), $86.6 million (Q4 2025), and $83.0 million (Q3 2025), per Business Quant data.